Overall Winner: Aidoc·67/ 100

Aidoc vs Hippocratic AI

In-depth comparison — valuation, funding, investors, founders & more

Winner
A
Aidoc

🇮🇱 Israel · Elad Walach

Series DAI HealthcareEst. 2016

Valuation

N/A

Total Funding

$370M

67
Awaira Score67/100

300 employees

Full Aidoc Profile →
H
Hippocratic AI

🇺🇸 United States · Munjal Shah

Series BAI HealthcareEst. 2023

Valuation

N/A

Total Funding

$120M

65
Awaira Score65/100

50-200 employees

Full Hippocratic AI Profile →
🔬

Analyst Summary

Generated from real data · No AI hallucinations

Both Aidoc and Hippocratic AI compete directly in the AI Healthcare space, making this a head-to-head matchup within the same market segment. Aidoc is an Israeli artificial intelligence company founded in 2016 that develops clinical decision support software for radiology and medical imaging. Hippocratic AI develops a safety-focused AI platform designed to address the global shortage of healthcare professionals by deploying AI agents that perform patient-facing healthcare communication tasks including care navigation, medication adherence outreach, chronic disease monitoring, and post-discharge follow-up.

Neither company has publicly disclosed a valuation at this time. On the funding side, Aidoc has raised $370M in total — $250M more than Hippocratic AI's $120M.

Aidoc has 7 years more market experience, having been founded in 2016 compared to Hippocratic AI's 2023 founding. In terms of growth stage, Aidoc is at Series D while Hippocratic AI is at Series B — a meaningful difference for investors evaluating risk and upside.

Aidoc operates out of 🇮🇱 Israel while Hippocratic AI is based in 🇺🇸 United States, giving each a distinct home-market advantage. On Awaira's 0–100 composite score, both companies are closely matched — Aidoc scores 67 and Hippocratic AI scores 65.

Metrics Comparison

MetricAidocHippocratic AI
💰Valuation
N/A
N/A
📈Total Funding
$370MWINS
$120M
📅Founded
2016
2023WINS
🚀Stage
Series D
Series B
👥Employees
300
50-200
🌍Country
Israel
United States
🏷️Category
AI Healthcare
AI Healthcare
Awaira Score
67WINS
65

Key Differences

📈

Funding gap: Aidoc has raised $250M more ($370M vs $120M)

📅

Market experience: Aidoc has 7 years more (founded 2016 vs 2023)

🚀

Growth stage: Aidoc is at Series D vs Hippocratic AI at Series B

👥

Team size: Aidoc has 300 employees vs Hippocratic AI's 50-200

🌍

Market base: 🇮🇱 Aidoc (Israel) vs 🇺🇸 Hippocratic AI (United States)

⚔️

Direct competitors: Both operate in the AI Healthcare market segment

Awaira Score: Aidoc scores 67/100 vs Hippocratic AI's 65/100

Which Should You Choose?

Use these signals to make the right call

A

Choose Aidoc if…

Top Pick
  • Higher Awaira Score — 67/100 vs 65/100
  • Stronger investor backing — raised $370M
  • More market experience — founded in 2016
  • Israel-based for regional compliance or proximity
  • Aidoc is an Israeli artificial intelligence company founded in 2016 that develops clinical decision support software for radiology and medical imaging
H

Choose Hippocratic AI if…

  • United States-based for regional compliance or proximity
  • Hippocratic AI develops a safety-focused AI platform designed to address the global shortage of healthcare professionals by deploying AI agents that perform patient-facing healthcare communication tasks including care navigation, medication adherence outreach, chronic disease monitoring, and post-discharge follow-up

Funding History

Aidoc raised $370M across 8 rounds. Hippocratic AI raised $120M across 0 rounds.

Aidoc

Series D

Dec 2021

Lead: Insight Partners

$256M

Series D

Jun 2021

Lead: Macquarie Group

$218M

Series C

Sep 2020

Lead: Khosla Ventures

$80M

Series C

Sep 2020

Lead: Ibex Investors

$80M

Series B

Jan 2019

Lead: GE Ventures

$22M

Series B

Jan 2019

Lead: Khosla Ventures

$60M

Series A

Jan 2018

$12M

Series A

Jan 2018

Lead: Pitango VC

$12M

Hippocratic AI

No public funding data available.

Investor Comparison

No shared investors detected between these two companies.

Unique to Aidoc

Pitango VCShasta VenturesIbex InvestorsInsight PartnersGoldman SachsMacquarie Group

Users Also Compare

FAQ — Aidoc vs Hippocratic AI

Is Aidoc bigger than Hippocratic AI?
Neither company has publicly disclosed a valuation, making a definitive size comparison difficult. Aidoc employs 300 people, while Hippocratic AI has 50-200 employees.
Which company raised more funding — Aidoc or Hippocratic AI?
Aidoc has raised more in total funding at $370M, compared to Hippocratic AI's $120M — a gap of $250M. Combined, the two companies have completed 8 known funding rounds.
Which company has a higher Awaira Score?
Aidoc holds the higher Awaira Score at 67/100, compared to Hippocratic AI's 65/100. The Awaira Score is a composite metric factoring in valuation, funding, stage, team size, and market presence — a 2-point gap that reflects meaningful differences in scale or traction.
Who founded Aidoc vs Hippocratic AI?
Aidoc was founded by Elad Walach in 2016. Hippocratic AI was founded by Munjal Shah in 2023. Visit each company's profile on Awaira for a full founder biography.
What does Aidoc do vs Hippocratic AI?
Aidoc: Aidoc is an Israeli artificial intelligence company founded in 2016 that develops clinical decision support software for radiology and medical imaging. The platform uses deep learning algorithms to analyze medical images, prioritize critical findings, and alert radiologists to potential abnormalities, particularly focusing on conditions requiring urgent intervention. Aidoc's core offering integrates into existing hospital workflows and PACS systems, enabling radiologists to identify and triage high-risk cases more efficiently. The company operates in the clinical AI segment, competing with firms like Zebra Medical Vision and Enlitic in automated imaging analysis. Aidoc's technology addresses the growing bottleneck of radiologist workload and diagnostic delays by automating preliminary image screening and flagging priority cases. The platform reportedly covers multiple pathologies including stroke, pulmonary embolism, and other acute conditions. As of the latest available data, Aidoc has secured $370 million in total funding through Series D stage, though its valuation remains not disclosed. The company has expanded internationally and serves healthcare institutions across multiple regions. Aidoc's growth trajectory reflects increasing institutional adoption of AI-assisted diagnostic tools in radiology departments globally, driven by workforce shortages and demand for faster diagnostic turnaround times in clinical settings. Aidoc focuses on clinical workflow integration rather than replacement, embedding AI directly into existing radiology infrastructure to accelerate diagnostic processes. Hippocratic AI: Hippocratic AI develops a safety-focused AI platform designed to address the global shortage of healthcare professionals by deploying AI agents that perform patient-facing healthcare communication tasks including care navigation, medication adherence outreach, chronic disease monitoring, and post-discharge follow-up. The platform is built around a healthcare-specific large language model with extensive safety evaluation against clinical benchmarks.\n\nThe company raised approximately 120 million USD in early rounds and has established partnerships with health systems and payers focused on reducing care gaps and improving patient engagement at scale. Hippocratic positions its AI as augmenting the healthcare workforce rather than replacing clinicians, targeting the vast volume of lower-acuity patient interactions that do not require physician judgment.\n\nThe healthcare staffing shortage is a structural problem projected to worsen over the next decade, creating durable demand for AI solutions that extend the capacity of existing clinical teams. Hippocratic AI competes with ambient clinical AI companies and general-purpose AI assistant platforms, but its narrow vertical focus on patient-facing healthcare communication and its safety-first design philosophy position it to navigate the regulatory and liability landscape that general AI platforms are less equipped to manage.
Which company was founded first?
Aidoc was founded first in 2016, giving it 7 years of additional market experience. Hippocratic AI was founded later in 2023. In AI, even a year or two of head start can translate into significantly more training data, customer relationships, and institutional knowledge.
Which company has more employees?
Aidoc has approximately 300 employees, while Hippocratic AI has approximately 50-200. A larger team often signals higher revenue or venture backing, but in AI, smaller teams are increasingly capable of building at scale.
Are Aidoc and Hippocratic AI competitors?
Yes, Aidoc and Hippocratic AI are direct competitors — both operate in the AI Healthcare space and likely target overlapping customer segments. This comparison is especially relevant for buyers evaluating both platforms.